SERVE-HF participants were randomly assigned to receive guideline-based medical treatment alone (control) or guideline-based medical treatment with ASV (Auto Set CS, ResMed). Full details of ASV titration and settings have been reported previously (10 (link)). Substudy evaluations such as PSG were performed at baseline, and at 3 and 12 months after randomization. The substudy was completed when all 312 patients had been followed for 12 months.
Fisser C., Gall L., Bureck J., Vaas V., Priefert J., Fredersdorf S., Zeman F., Linz D., Woehrle H., Tamisier R., Teschler H., Cowie M.R, & Arzt M. (2022). Effects of Adaptive Servo-Ventilation on Nocturnal Ventricular Arrhythmia in Heart Failure Patients With Reduced Ejection Fraction and Central Sleep Apnea–An Analysis From the SERVE-HF Major Substudy. Frontiers in Cardiovascular Medicine, 9, 896917.
Other organizations :
University Hospital Regensburg, Radboud University Nijmegen, Radboud University Medical Center, Maastricht University Medical Centre, Royal Adelaide Hospital, University of Adelaide, University of Copenhagen, Université Grenoble Alpes, Inserm, Centre Hospitalier Universitaire de Grenoble, Ruhrlandklinik, King's College London, Royal Brompton Hospital
Guideline-based medical treatment with ASV (Auto Set CS, ResMed)
dependent variables
Outcomes measured at baseline, 3 months, and 12 months (e.g., PSG)
control variables
Guideline-based medical treatment
controls
Guideline-based medical treatment alone (control)
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
